"Roaring Fork Neurology blends whole-person care in our nourishing brain center and spa with the best of Western diagnostics and treatment options. Dr. Brooke Allen, Carly Stillman, PA-C and Lara Kroepsch, PA-C specialize in diagnosing and treating disorders of the nervous system including diseases and injury of the brain, spinal cord, nerves, and muscles. Our special interests include multiple sclerosis and headache. Our NeuroSpa treatments empower our patients to heal from the inside out with care for the entire brain, body and being."

During the past decade, Mountain Neurological Research Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mountain Neurological Research Center" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Cassava Sciences, Inc." with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mountain Neurological Research Center" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Mountain Neurological Research Center" are "Alzheimer Disease" (3 trials), "Multiple Sclerosis" (3 trials), "Migraine" (2 trials), "Alzheimer's Disease" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Mountain Neurological Research Center" in a lesser frequency.

Most popular intervention types in "Mountain Neurological Research Center" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ocrelizumab" (3 trials), "Antihistamine" (2 trials), "Donanemab" (2 trials) and "Erenumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mountain Neurological Research Center" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Mountain Neurological Research Center". undefined are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mountain Neurological Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mountain Neurological Research Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Mountain Neurological Research Center has several departments that took part in Clinical trials: "Mountain Neurological Research Center, Inc.-Site Number:8400128" - 2 trials